(Q34182135)

English

Orlistat in the treatment of obesity

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

title

Orlistat in the treatment of obesity. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

A Ballinger

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

published in

Expert Opinion on Pharmacotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

volume

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

page(s)

841-847

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

cites work

Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.841

retrieved

21 January 2018

A 3-month, double-blind, controlled trial of feeding with sucrose polyester in human volunteers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.841

retrieved

21 January 2018

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.841

retrieved

21 January 2018

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.841

retrieved

21 January 2018

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.841

retrieved

21 January 2018

Identifiers

DOI

10.1517/14656566.1.4.841

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

PubMed publication ID

11249520

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249520

retrieved

31 July 2017

(Q34182135)

Orlistat in the treatment of obesity

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)